The test detects up to 25 viral and bacterial targets, including SARS-CoV-2, influenza, Bordetella pertussis, and RSV, in one patient sample.
In February, the US Food and Drug Administration granted 510(k) clearance to a dozen in vitro diagnostic tests encompassing molecular, immunoassay, clinical chemistry, and ion selective electrode ...